Overview

Chronic kidney disease (CKD) is a significant and growing public health problem. It is currently estimated that 13% of the adult population has CKD and it confers a 5-fold increased risk of premature cardiovascular disease and death. Those who survive long enough eventually require renal replacement therapy with dialysis or a kidney transplant. Many of the risk factors for CKD begin in childhood. a patient develops CKD, the pathological changes that worsen dysfunction are similar in all kidney diseases, and are characterized by a process of ongoing scarring or fibrosis. Despite tremendous progress in our understanding of the causes and consequences of CKD, effective therapies are unknown. Using experimental models of CKD, our studies are designed to investigate how specific cells and molecules mediate kidney fibrosis, with the ultimate goal of translating our findings into new human therapies.

Publications

Range and Heterogeneity of Outcomes in Randomized Trials of Pediatric Chronic Kidney Disease.
The Journal of pediatrics
DOI: 10.1016/j.jpeds.2017.03.034
PubMed: 28449820
07/2017

Standardised Outcomes in Nephrology-Children and Adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney disease.
Tong A and Samuel S and Zappitelli M and Dart A and Furth S and Eddy A and Groothoff J and Webb NJ and Yap HK and Bockenhauer D and Sinha A and Alexander SI and Goldstein SL and Gipson DS and Hanson CS and Evangelidis N and Crowe S and Harris T and Hemmelgarn BR and Manns B
DOI: 10.1186/s13063-016-1528-5
PubMed: 27519274
2016

The impact of small kidneys.
Pediatric nephrology (Berlin, Germany)
DOI: 10.1007/s00467-015-3079-5
PubMed: 25794549
09/2015

Overview of the cellular and molecular basis of kidney fibrosis.
Eddy AA
DOI: 10.1038/kisup.2014.2
PubMed: 25401038
11/2014

Cysteamine modulates oxidative stress and blocks myofibroblast activity in CKD.
Okamura DM and Bahrami NM and Ren S and Pasichnyk K and Williams JM and Gangoiti JA and Lopez-Guisa JM and Yamaguchi I and Barshop BA and Duffield JS and Eddy AA
DOI: 10.1681/asn.2012090962
PubMed: 24009239
01/2014

The Canadian Childhood Nephrotic Syndrome (CHILDNEPH) Project: overview of design and methods.
Samuel S and Scott S and Morgan C and Dart A and Mammen C and Parekh R and Nettel-Aguirre A and Eddy A and Flynn R and Pinsk M and Wade A and Arora S and Benoit G and Bitzan M and Erickson R and Feber J and Filler G and Geier P and Girardin C and Grisaru S
DOI: 10.1186/2054-3581-1-17
PubMed: 25960884
2014

Acute kidney injury and its association with in-hospital mortality among children with acute infections.
Imani PD and Odiit A and Hingorani SR and Weiss NS and Eddy AA
DOI: 10.1007/s00467-013-2544-2
PubMed: 23872929
11/2013

Social paediatrics: From 'lip service' to the health and well-being of Canada's children and youth.
Daneman D and Kellner J and Bernstein M and Dow K and Dugas MA and Duffy C and Eddy A and Filler G and Frappier JY and Gilmour S and Givelichian L and Huang L and Rockman-Greenberg C and Shevell M and Vardy C and Walti H and Orrbine E and Williams M
PubMed: 24421706
08/2013

The origin of scar-forming kidney myofibroblasts.
Eddy AA
DOI: 10.1038/nm.3299
PubMed: 23921738
08/2013

Rising part-time work in the academic pediatric workforce in Canada.
Filler G and Givelichian L and Walti H and Piedboeuf B and Pediatric Chairs of Canada
DOI: 10.1016/j.jpeds.2013.04.040
PubMed: 23885849
08/2013

Investigating mechanisms of chronic kidney disease in mouse models.
Eddy AA and López-Guisa JM and Okamura DM and Yamaguchi I
DOI: 10.1007/s00467-011-1938-2
PubMed: 21695449
08/2012

Albumin-induced apoptosis of glomerular parietal epithelial cells is modulated by extracellular signal-regulated kinase 1/2.
Chang AM and Ohse T and Krofft RD and Wu JS and Eddy AA and Pippin JW and Shankland SJ
DOI: 10.1093/ndt/gfr483
PubMed: 21896500
04/2012

Mannose receptor 2 attenuates renal fibrosis.
López-Guisa JM and Cai X and Collins SJ and Yamaguchi I and Okamura DM and Bugge TH and Isacke CM and Emson CL and Turner SM and Shankland SJ and Eddy AA
DOI: 10.1681/asn.2011030310
PubMed: 22095946
02/2012

Vascular endothelial cadherin modulates renal interstitial fibrosis.
Yamaguchi I and Tchao BN and Burger ML and Yamada M and Hyodo T and Giampietro C and Eddy AA
DOI: 10.1159/000332026
PubMed: 22126970
2012

The TGF-ß route to renal fibrosis is not linear: the miR-21 viaduct.
Eddy AA
DOI: 10.1681/asn.2011070698
PubMed: 21836141
09/2011

Scraping fibrosis: UMODulating renal fibrosis.
Eddy AA
DOI: 10.1038/nm0511-553
PubMed: 21546974
05/2011

Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis.
Okamura DM and Pasichnyk K and Lopez-Guisa JM and Collins S and Hsu DK and Liu FT and Eddy AA
DOI: 10.1152/ajprenal.00326.2010
PubMed: 20962111
01/2011

Nicotinic acetylcholine receptor a1 promotes calpain-1 activation and macrophage inflammation in hypercholesterolemic nephropathy.
Zhang G and Thomas AL and Marshall AL and Kernan KA and Su Y and Zheng Y and Takano J and Saido TC and Eddy AA
DOI: 10.1038/labinvest.2010.135
PubMed: 20661225
01/2011

A novel signaling pathway: fibroblast nicotinic receptor alpha1 binds urokinase and promotes renal fibrosis.
Zhang G and Kernan KA and Thomas A and Collins S and Song Y and Li L and Zhu W and Leboeuf RC and Eddy AA
DOI: 10.1074/jbc.m109.010249
PubMed: 19690163
10/2009

Serine proteases, inhibitors and receptors in renal fibrosis.
Eddy AA
PubMed: 19350108
04/2009

CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD.
Okamura DM and Pennathur S and Pasichnyk K and López-Guisa JM and Collins S and Febbraio M and Heinecke J and Eddy AA
DOI: 10.1681/asn.2008010009
PubMed: 19211715
03/2009

Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group.
Joy MS and Gipson DS and Dike M and Powell L and Thompson A and Vento S and Eddy A and Fogo AB and Kopp JB and Cattran D and Trachtman H
DOI: 10.2215/cjn.02310508
PubMed: 19073787
01/2009

Macrophage diversity in renal injury and repair.
Ricardo SD and van Goor H and Eddy AA
DOI: 10.1172/jci36150
PubMed: 18982158
11/2008

Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy.
Tang SC and Leung JC and Chan LY and Eddy AA and Lai KN
DOI: 10.1038/sj.ki.5002674
PubMed: 18033243
02/2008

Urokinase and its receptors in chronic kidney disease.
Zhang G and Eddy AA
DOI: 10.2741/3093
PubMed: 18508599
2008

Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury.
Okamura DM and López-Guisa JM and Koelsch K and Collins S and Eddy AA
DOI: 10.1152/ajprenal.00063.2007
PubMed: 17537985
08/2007

Endogenous urokinase lacks antifibrotic activity during progressive renal injury.
Yamaguchi I and Lopez-Guisa JM and Cai X and Collins SJ and Okamura DM and Eddy AA
DOI: 10.1152/ajprenal.00380.2006
PubMed: 17356128
07/2007

Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals.
Zhang G and Kernan KA and Collins SJ and Cai X and López-Guisa JM and Degen JL and Shvil Y and Eddy AA
DOI: 10.1681/asn.2006080886
PubMed: 17267741
03/2007

Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action.
Eddy AA and Fogo AB
DOI: 10.1681/asn.2006050503
PubMed: 17035608
11/2006

Chronic kidney disease progression.
Eddy AA and Neilson EG
DOI: 10.1681/asn.2006070704
PubMed: 17035605
11/2006

Ramping up endogenous defences against chronic kidney disease.
Eddy AA
DOI: 10.1093/ndt/gfl102
PubMed: 16574685
05/2006

Subepithelial humps and microthrombi: looking for a mechanism.
Simon D and Finn L and Eddy A
DOI: 10.1053/j.ajkd.2005.07.052
PubMed: 16431268
02/2006

Plasminogen activator inhibitor-1 deficiency has renal benefits but some adverse systemic consequences in diabetic mice.
Collins SJ and Alexander SL and Lopez-Guisa JM and Cai X and Maruvada R and Chua SC and Zhang G and Okamura DM and Matsuo S and Eddy AA
PubMed: 16735799
2006

Progression in chronic kidney disease.
Eddy AA
DOI: 10.1053/j.ackd.2005.07.011
PubMed: 16198274
10/2005

Can renal fibrosis be reversed?
Eddy AA
DOI: 10.1007/s00467-005-1995-5
PubMed: 15947978
10/2005

Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice.
Matsuo S and López-Guisa JM and Cai X and Okamura DM and Alpers CE and Bumgarner RE and Peters MA and Zhang G and Eddy AA
DOI: 10.1111/j.1523-1755.2005.00327.x
PubMed: 15882265
06/2005

Why is proteinuria an ominous biomarker of progressive kidney disease?
Zandi-Nejad K and Eddy AA and Glassock RJ and Brenner BM
PubMed: 15485426
11/2004

Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
Zhang G and Cai X and López-Guisa JM and Collins SJ and Eddy AA
DOI: 10.1097/01.asn.0000135057.41526.2c
PubMed: 15284295
08/2004

The NPHP1 gene deletion associated with juvenile nephronophthisis is present in a subset of individuals with Joubert syndrome.
Parisi MA and Bennett CL and Eckert ML and Dobyns WB and Gleeson JG and Shaw DW and McDonald R and Eddy A and Chance PF and Glass IA
DOI: 10.1086/421846
PubMed: 15138899
07/2004

Expression of nephrin in acquired forms of nephrotic syndrome in childhood.
Hingorani SR and Finn LS and Kowalewska J and McDonald RA and Eddy AA
DOI: 10.1007/s00467-003-1346-3
PubMed: 14747939
03/2004

Proteinuria and interstitial injury.
Eddy AA
DOI: 10.1093/ndt/gfg533
PubMed: 14736944
02/2004

Nephrotic syndrome in childhood.
Eddy AA and Symons JM
DOI: 10.1016/s0140-6736(03)14184-0
PubMed: 12944064
08/2003

Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy.
Zhang G and Kim H and Cai X and López-Guisa JM and Alpers CE and Liu Y and Carmeliet P and Eddy AA
DOI: 10.1097/01.asn.0000064292.37793.fb
PubMed: 12707394
05/2003

Urokinase receptor modulates cellular and angiogenic responses in obstructive nephropathy.
Zhang G and Kim H and Cai X and Lopez-Guisa JM and Carmeliet P and Eddy AA
DOI: 10.1097/01.asn.0000064701.70231.3f
PubMed: 12707393
05/2003

Longterm followup of childhood lupus nephritis.
Hagelberg S and Lee Y and Bargman J and Mah G and Schneider R and Laskin C and Eddy A and Gladman D and Urowitz M and Hebert D and Silverman E
PubMed: 12465165
12/2002

An introduction to frontiers in nephrology.
Eddy AA and Couser WG
DOI: 10.1097/01.asn.0000026725.09795.90
PubMed: 12138153
08/2002

Plasminogen activator inhibitor-1 and the kidney.
Eddy AA
PubMed: 12110504
08/2002

PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction.
Oda T and Jung YO and Kim HS and Cai X and López-Guisa JM and Ikeda Y and Eddy AA
DOI: 10.1046/j.1523-1755.2001.030002587.x
PubMed: 11473641
08/2001

Mast cells find their way to the kidney.
Eddy AA
DOI: 10.1046/j.1523-1755.2001.00811.x
PubMed: 11422775
07/2001

TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy.
Kim H and Oda T and López-Guisa J and Wing D and Edwards DR and Soloway PD and Eddy AA
PubMed: 11274235
04/2001

Role of cellular infiltrates in response to proteinuria.
Eddy A
PubMed: 11158857
01/2001

Molecular basis of renal fibrosis.
Eddy AA
DOI: 10.1007/s004670000461
PubMed: 11149129
12/2000

Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective.
Eddy AA and Kim H and López-Guisa J and Oda T and Soloway PD
DOI: 10.1046/j.1523-1755.2000.00208.x
PubMed: 10916085
08/2000

Renal remodelling in dietary protein modified rat polycystic kidney disease.
Bankovic-Calic N and Eddy A and Sareen S and Ogborn MR
DOI: 10.1007/s004670050744
PubMed: 10460502
09/1999

Tubulointerstitial nephritis and uveitis in children and adolescents. Four new cases and a review of the literature.
Vohra S and Eddy A and Levin AV and Taylor G and Laxer RM
DOI: 10.1007/s004670050634
PubMed: 10412864
06/1999

A morbid course in a girl with mixed connective tissue disease.
Essalah AA and Eddy AA
DOI: 10.1007/s004670050562
PubMed: 10100290
01/1999

The nephrotic syndrome: from the simple to the complex.
Eddy AA and Schnaper HW
PubMed: 9613871
05/1998

Interstitial fibrosis in hypercholesterolemic rats: role of oxidation, matrix synthesis, and proteolytic cascades.
Eddy AA
DOI: 10.1046/j.1523-1755.1998.00889.x
PubMed: 9573532
05/1998

Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome.
Drukker A and Eddy AA
PubMed: 9527400
02/1998

Molecular insights into renal interstitial fibrosis.
Eddy AA
PubMed: 8989727
12/1996

Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia.
Eddy AA
DOI: 10.1038/ki.1996.421
PubMed: 8887271
10/1996

Expression of genes that promote renal interstitial fibrosis in rats with proteinuria.
Eddy AA
PubMed: 8731195
05/1996

Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis.
Press J and Palayew K and Laxer RM and Elkon K and Eddy A and Rakoff D and Silverman ED
DOI: 10.1002/art.1780390420
PubMed: 8630119
04/1996

Expression and function of monocyte chemoattractant protein-1 in experimental nephrotic syndrome.
Eddy AA and Warren JS
DOI: 10.1006/clin.1996.0023
PubMed: 8625556
02/1996

An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes.
Zhang L and Eddy A and Teng YT and Fritzler M and Kluppel M and Melet F and Bernstein A
DOI: 10.1128/mcb.15.12.6961
PubMed: 8524263
12/1995

Neurologic manifestations of pediatric systemic lupus erythematosus.
Steinlin MI and Blaser SI and Gilday DL and Eddy AA and Logan WJ and Laxer RM and Silverman ED
DOI: 10.1016/0887-8994(95)00110-2
PubMed: 8554655
10/1995

Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions.
Eddy AA
PubMed: 7893992
12/1994

Protein restriction reduces transforming growth factor-beta and interstitial fibrosis in nephrotic syndrome.
Eddy AA
PubMed: 8023968
06/1994

Xanthogranulomatous pyelonephritis in children. Etiology, pathogenesis, clinical and radiologic features, and management.
Levy M and Baumal R and Eddy AA
PubMed: 8200171
06/1994

Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats.
Jones CL and Buch S and Post M and McCulloch L and Liu E and Eddy AA
PubMed: 1281619
12/1992

Tubulointerstitial nephritis.
Jones CL and Eddy AA
DOI: 10.1007/bf00866512
PubMed: 1482649
11/1992

Intrarenal distribution of clusterin following reduction of renal mass.
Correa-Rotter R and Hostetter TH and Manivel JC and Eddy AA and Rosenberg ME
DOI: 10.1038/ki.1992.144
PubMed: 1513115
04/1992

The contribution of antibody-mediated cytotoxicity and immune-complex formation to tubulointerstitial disease in passive Heymann nephritis.
Eddy AA and Ho GC and Thorner PS
DOI: 10.1016/0090-1229(92)90021-f
PubMed: 1728979
01/1992

Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis.
Jones CL and Buch S and Post M and McCulloch L and Liu E and Eddy AA
DOI: 10.1038/ki.1991.310
PubMed: 1762303
12/1991

Pulmonary hemorrhage and necrotizing glomerulonephritis without glomerular immune deposits: report of two cases.
Jones CL and Shields M and Eddy AA and Baumal R and O'Neill M and Geary DF
DOI: 10.1016/s0272-6386(12)80887-0
PubMed: 1867183
08/1991

Presence of thyroid abnormalities in children with systemic lupus erythematosus.
Eberhard BA and Laxer RM and Eddy AA and Silverman ED
DOI: 10.1016/s0022-3476(05)80741-3
PubMed: 1861215
08/1991

A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome.
Eddy AA and McCulloch L and Liu E and Adams J
PubMed: 2024704
05/1991

Localization of clusterin in the epimembranous deposits of passive Heymann nephritis.
Eddy AA and Fritz IB
DOI: 10.1038/ki.1991.29
PubMed: 2002638
02/1991

Tubulointerstitial nephritis during the heterologous phase of nephrotoxic serum nephritis.
Eddy AA
PubMed: 1956493
1991

Intraglomerular leukocyte recruitment during nephrotoxic serum nephritis in rats.
Eddy AA and McCulloch LM and Adams JA
DOI: 10.1016/0090-1229(90)90118-a
PubMed: 2245521
12/1990

Coagulation abnormalities in chronic peritoneal dialysis.
Jones CL and Andrew M and Eddy A and O'Neil M and Shalom NI and Balfe JW
DOI: 10.1007/bf00858827
PubMed: 2397181
03/1990

A study by immunofluorescence microscopy of the NC1 domain of collagen type IV in glomerular basement membranes of two patients with hereditary nephritis.
Thorner PS and Baumal R and Eddy A and Marrano PM
DOI: 10.1007/bf01678979
PubMed: 2105558
1990

Prolongation of acute renal failure in two patients with hemolytic-uremic syndrome due to excessive plasma infusion therapy.
Eddy AA and Geary DF and Balfe JW and Clark WF and Baumal R
DOI: 10.1007/bf00850219
PubMed: 2642111
10/1989

Interstitial nephritis induced by protein-overload proteinuria.
Eddy AA
PubMed: 2801886
10/1989

Characterization of the NC1 domain of collagen type IV in glomerular basement membranes (GBM) and of antibodies to GBM in a patient with anti-GBM nephritis.
Thorner PS and Baumal R and Eddy A and Marrano P
PubMed: 2706812
03/1989

Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis.
Eddy AA and Michael AF
DOI: 10.1038/ki.1988.3
PubMed: 3258389
01/1988

Identification of lymphohemopoietic cells in the kidneys of normal rats.
Eddy AA and Crary GS and Michael AF
PubMed: 3488687
08/1986

Subtotal nephrectomy in the rabbit: a model of chronic hypercalcemia, nephrolithiasis, and obstructive nephropathy.
Eddy AA and Falk RJ and Sibley RK and Hostetter TH
PubMed: 3711720
06/1986

Decreased plasma fibronectin levels in children with hemolytic-uremic syndrome.
Cosio FG and Eddy A and Mentser MI and Bergstein JM
DOI: 10.1016/0002-9343(85)90394-8
PubMed: 3885728
04/1985

Pseudohermaphroditism, glomerulopathy, and Wilms tumor (Drash syndrome): frequency in end-stage renal failure.
Eddy AA and Mauer SM
DOI: 10.1016/s0022-3476(85)80076-7
PubMed: 2984395
04/1985

Renal allograft failure due to recurrent dense intramembranous deposit disease.
Eddy A and Sibley R and Mauer SM and Kim Y
PubMed: 6380848
06/1984

The distribution of the CR3 receptor on human cells and tissue as revealed by a monoclonal antibody.
Eddy A and Newman SL and Cosio F and LeBien T and Michael A
DOI: 10.1016/0090-1229(84)90090-4
PubMed: 6232029
06/1984

Immune cell populations in cutaneous delayed-type hypersensitivity.
Platt JL and Grant BW and Eddy AA and Michael AF
DOI: 10.1084/jem.158.4.1227
PubMed: 6604784
10/1983

Research
Grants

T32 DK07662 (Eddy PI). NIH/NRSA, Pediatric Nephrology Training Program, $274,895 current year. (2006-2016). The goal is to train academic pediatric nephrologists.

N/A (Okamura PI, Eddy Co-PI). Cystinosis Research Foundation, "Elucidating the Role of Cystinosin-Deficient Macrophages in Nephropathic Cystinosis", $218,966/2 years. (2011-2013). The goal of this project is to investigate the hypothesis that cystinosin deficiency leads to macrophage dysfunction that contributes to the pathogenesis of chronic kidney disease.

Pilot and Feasibility Grant (Eddy PI). Washington Global Health Alliance, Impact of Kidney Dysfunction on Mortality Rates in Ugandan Children Hospitalized with Acute Infections. $75,000. (2007-2010). The goal of this project is to establish a mechanism to evaluate renal function for children admitted to Mulago hospital with pneumonia, malaria and gastroenteritis and to determine the impact of renal failure on acute mortality rates.

Honours & Awards

Elected to the Council of the International Society of Pediatric Nephrology (1995-2001) and the International Society of Nephrology (2009-2015).

Scientific Program Committee Co-chair for triannual congresses on the International Society of Pediatric Nephrology in 1989, 2011 and 2013.

First recipient of The Robert O. Hickman Endowed Chair in Pediatric Nephrology, University of Washington (2007-2012).

Research Group Members

Olena Maydan, Research Assistant, Research Assistant
Juan Tellez, Digital Lab Manager
Nataliya Yuskiv, Research Coordinator
Sima Zakani, 3DPP Program Manager
Wenli Zhang, Data Coordinator